Takeda acquires Ariad Pharmaceuticals
Takeda Pharmaceutical has completed its acquisition of Ariad Pharmaceuticals for $24.00 per share in cash.
Takeda Pharmaceutical has completed its acquisition of Ariad Pharmaceuticals for $24.00 per share in cash.
Sanofi has agreed to divest five of its over-the-counter consumer healthcare products in Europe to French pharma firm Ipsen for €83m.
Reckitt Benckiser (RB) has agreed to acquire Mead Johnson Nutrition for $90 in cash for each share of common stock, valuing the total equity at $16.6bn.
GE Healthcare’s FlexFactory manufacturing platform has been selected to expand production capacity at Arven Pharmaceuticals' facility in Kirklareli, Turkey.
Japan's Takeda Pharmaceutical has agreed to acquire US cancer drug maker Ariad Pharmaceuticals in a transaction worth about $5.2bn.